FEB 13, 2019 1:30 PM PST

Precision Medicine for Mice: Digital Biomarkers Transforming Drug Discovery

Speaker
  • Chief Scientific Officer, Vium
    Biography
      Laura Schaevitz has more than 20 years of experience with In vivo animal studies. As Chief Scientific Officer at Vium, she oversees the development of animal models and draws upon her experiences as a molecular and behavioral neuroscientist to direct the application of Vium's digital metrics to the animal models. In past experiences, Laura utilized a broad spectrum of mouse models including transgenic and nutrition-induced models of neurodevelopmental disorders such as autism, schizophrenia, Rett syndrome, and blindsight. Laura received her PhD in Neuroscience at Stanford University in 2006.

    Abstract

    Preclinical drug discovery is at the edge of a major transformation that promises to improve translation to the clinic through enhanced acquisition and advanced analysis of data. While an important part of the drug development process, currently preclinical studies do not always predict drug failure or success in the clinic. Limited predictive power is attributed to many factors including limited measurable parameters on a single animal, infrequent collection, and small sample sizes that are often captured under conditions that have the potential to alter the animal’s physiologic state and confound data interpretation. Digital biomarkers, captured continuously without handling, provide objective, sensitive, and clinically meaningful methods of monitoring disease and response to therapeutic interventions. This webinar reviews the the current state of digital biomarkers in preclinical studies and discusses the challenges and opportunities for more widespread adoption to improve translation of preclinical studies to the clinic.

    Learning Objectives: 

    1. Define digital biomarkers and current state in drug development
    2. Examine how high frequency capture of digital biomarkers provides objective, sensitive, and meaningful readouts of disease state and compound efficacy that may be more translatable to the clinic.
    3. Discuss challenges and opportunities for the future capture and analysis of digital biomarkers in preclinical studies


    Show Resources
    You May Also Like
    MAY 11, 2021 10:00 AM PDT
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    C.E. CREDITS
    MAY 11, 2021 10:00 AM PDT
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    Date: May 11, 2021 Time: 10:00zm PDT Your samples are some of the most valuable assets in the laboratory. After spending countless hours on extraction and preparation, your conclusions could...
    NOV 18, 2020 8:00 AM PST
    C.E. CREDITS
    NOV 18, 2020 8:00 AM PST
    DATE: November 18, 2020 TIME: 08:00am PDT We develop and implement technologies to solve some of the major bottlenecks in biomedical research. In particular, we establish new imaging approac...
    DEC 02, 2020 8:00 AM PST
    C.E. CREDITS
    DEC 02, 2020 8:00 AM PST
    DATE: December 2nd, 2020 TIME: 08:00am PDT, 11:00pm EDT Bioreactors and shakers are used to cultivate microorganisms, plant, insect, and mammalian cells in different volumes. Upscaling of pr...
    JUN 09, 2021 7:00 AM PDT
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    C.E. CREDITS
    JUN 09, 2021 7:00 AM PDT
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    Date: June 9, 2021 Time: 09 June 2021, 7am PDT, 10am EDT, 4pm CEST cells with dramatic implications on the validity of past cell culture related research. The fact that at least 509 cell lin...
    NOV 16, 2020 8:00 AM PST
    C.E. CREDITS
    NOV 16, 2020 8:00 AM PST
    Date: November 16, 2020 Time: 8:00am (PST), 11:00am (EST) CRISPR screening has become the prime discovery tool in modern biomedical research and drug discovery. At the same time, most screen...
    APR 01, 2021 8:00 AM PDT
    C.E. CREDITS
    APR 01, 2021 8:00 AM PDT
    Date: April 01, 2021 Time: 8:00am (PST), 11:00am (EST) Generating therapeutic antibodies is far more challenging than obtaining antibodies that merely recognize their targets. Engineering po...
    FEB 13, 2019 1:30 PM PST

    Precision Medicine for Mice: Digital Biomarkers Transforming Drug Discovery


    Specialty

    Animal Research

    Animal Models

    Animal Sciences

    Animal Behavior

    Immunology

    Veterinary Sciences

    Cancer Research

    Life Science

    Lab Animals

    Cell Biology

    Research

    Molecular Biology

    Brain

    Animals

    Research And Development

    Geography

    Europe82%

    North America14%

    Asia2%

    Registration Source

    Website Visitors100%

    Job Title

    Research Scientist22%

    Student14%

    Medical Laboratory Technician13%

    Post Doc12%

    Medical Doctor/Specialist11%

    Scientist6%

    Clinical Laboratory Scientist4%

    Biologist3%

    Facility/Department Manager3%

    Animal Care Lab Technician3%

    Educator/Faculty2%

    Executive2%

    Veterinarian2%

    Veterinary Technician1%

    Lab Management1%

    Organization

    Academic Institution49%

    Hospital15%

    Research Institute11%

    Pharmaceutical Company4%

    Industrial Company3%

    Clinical Laboratory3%

    Medical Center3%

    Ambulatory Care2%

    Consultant1%

    Retired1%

    Medical School1%

    Contract Research Organization (Cro)1%

    Life Science Company1%

    Government/public1%

    Other2%


    Show Resources
    Loading Comments...
    Show Resources
    Attendees
    • See more